Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_869_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Preface
- •Contents
- •Contributors
- •Future of TAMIS
- •Conclusion
- •References
- •1: Historical Perspectives and Rationale for Development
- •Introduction
- •From Miles Resection to Parks Excision
- •Transanal Endoscopic Microsurgery (TEM)
- •Transanal Minimally Invasive Surgery (TAMIS)
- •Introduction
- •Indications
- •Contraindications
- •Controversial Areas
- •Conclusion
- •References
- •3: An Algorithm for Local Excision for Early-Stage Rectal Cancer
- •Background
- •Techniques for Local Excision
- •Traditional Indications for Local Excision
- •Risk Factors for Failure of Local Excision of Early Rectal Cancer
- •Results of Local Excision of T1 Rectal Cancer
- •Local Excision of T2 Rectal Cancer
- •NCCN and National Guidelines
- •Patient-Related Factors
- •Technical and Surgeon-Related Factors
- •Salvage of Recurrence After Local Excision
- •An Algorithm
- •Conclusions
- •References
- •Introduction
- •Intervals After nCRT
- •Radiological Assessment
- •Transanal Full-Thickness Local Excisions (FTLEs)
- •Outcomes
- •References
- •Introduction
- •Summary
- •Conclusion
- •References
- •Introduction
- •Treatment Options
- •Local Excision
- •Neoadjuvant Therapy Followed by Local Excision
- •Palliative Radiotherapy
- •Radical Surgery
- •Conclusion: Tailoring Palliative Treatment
- •References
- •Introduction
- •History
- •History of Transanal Access Excluding Endoscopy
- •Flexible Sigmoidoscopy
- •Transanal Endoscopic Microsurgery
- •SILS, TAMIS, and the Glove Port
- •Transanal Access Platforms
- •Transanal Retractors
- •Operating Sigmoidoscopes
- •Lone Star Retractor
- •TAMIS
- •GelPOINT Path Transanal Access Platform
- •SILS
- •OCTO Port
- •Robotic-Assisted TAMIS
- •Transanal Instrumentation
- •Ordinary Laparoscopic Instruments
- •Suturing Devices
- •Diathermy
- •Energy Devices
- •The Gas Laws
- •Compliance
- •ISB and EPIX
- •Summary
- •References
- •8: Operating Theater Setup and Perioperative Considerations
- •Introduction
- •Equipment
- •Essential Equipment
- •Recommended
- •Operating Theater Setup
- •Perioperative Considerations
- •Patient Selection
- •TAMIS
- •Other Considerations
- •Postoperative Care
- •Conclusion
- •References
- •Introduction
- •Patient Selection
- •Operative Technique
- •Patients’ Eligibility for ELRR (Pyramidal Local Excision)
- •Basic Exclusion Criteria
- •Conclusions
- •References
- •10: Pyramidal Excision for Early Rectal Cancer and Special Closure Techniques
- •Nomenclature: Excision versus Resection
- •Rationale of Pyramidal Excision
- •Patient Selection
- •Index Staging (Pre-NT)
- •Neoadjuvant Therapy (NT)
- •Anesthesia
- •Pyramidal Excision or ELRR
- •Surgical Dissection
- •Posterior Lesions (Patient Supine)
- •Anteriol Lesions (Patient Prone)
- •Female
- •Male
- •Peritoneal Entry
- •Intraoperative Histological Assessment of the Cranial and Caudal Margins
- •Nucleotide-Guided Mesorectal Excision (NGME)
- •Suture Closure of the Defect
- •Important Tips
- •Conclusions
- •References
- •11: Closure Versus Non-closure After Local Excision
- •Introduction
- •References
- •Introduction
- •Intraoperative Complications
- •Peritoneal Entry
- •Intraoperative Hemorrhage
- •Short-Term Complications
- •Postoperative Hemorrhage
- •Subcutaneous Emphysema
- •Postoperative Pain
- •Fecal Incontinence
- •Long-Term Complications
- •Rectal Stricture
- •Rectovaginal Fistula
- •References
- •Introduction
- •Anorectal Function
- •Measuring Anorectal Function
- •Preoperative Evaluation
- •Physical Exam
- •Intraoperative Factors
- •Transanal Excision (TAE)
- •Transanal Endoscopic Microsurgery (TEM)
- •Fecal Incontinence Scores
- •Transanal Minimally Invasive Surgery (TAMIS)
- •Conclusions
- •References
- •Introduction
- •Recurrence After Local Excision
- •Summary
- •References
- •15: Applications Beyond Local Excision
- •Introduction
- •The TAMIS-Ileal Pouch-Anal Anastomosis (TaIPAA)
- •Pelvic Exenteration
- •Proctectomy
- •Rectal Prolapse
- •Parastomal Hernia
- •Retrorectal Masses
- •Robotic TAMIS
- •Managing Complications
- •Foreign Body Retrieval
- •Conclusions
- •References
- •Introduction
- •Initial Dry Laboratory Experiments
- •References
- •Introduction
- •Flex® Robotic System
- •Future Directions: da Vinci SP Surgical System
- •Future Directions: Pure NOTES Colorectal Surgery
- •Conclusions
- •References
- •Introduction
- •Oncologic Outcomes After Peritoneal Entry During TAMIS
- •Fecal Incontinence
- •Economics
- •Unusual Applications
- •References
- •19: Indications for Malignant Neoplasia of the Rectum
- •Operative Approach for TME
- •Abdominal TME
- •Transanal TME
- •Patient Selection
- •Tumor-Related Factors
- •Local Stage
- •Tumor Height
- •Patient-Related Factors
- •Obesity
- •Narrow Pelvis
- •Procedure-Related Factors
- •Following Local Excision with Transanal Endoscopic Surgery (TES)
- •Low/Ultra-Low Anterior Resection
- •Intersphincteric Dissection
- •Abdominoperineal Resection
- •Patient Counselling
- •Surgeon Training and Experience
- •Summary
- •References
- •Introduction
- •Technique
- •Preliminary Results
- •Surgical Approach
- •Results
- •Heading
- •Surgical Technique
- •Surgical Technique
- •Preliminary Results
- •Miscellaneous Procedures
- •Final Remarks
- •References
- •Introduction
- •Operating Theater Setup
- •Two-Team Coordination: Low Anterior Resection
- •Transanal Team: Transanal Proctectomy
- •Abdominal Team: Upper Rectal Mobilization
- •References
- •22: Single-Team taTME
- •Introduction
- •Considerations
- •Institution
- •Advocating for a Single-Team taTME Program
- •Securing Sustainable Funding
- •Patient Consent
- •Potential Complications
- •Training
- •Required Personnel
- •Surgeon
- •Specialized Assistant
- •Dedicated Nursing Team
- •Equipment
- •Equipment Setup for a Single Team
- •The Procedure
- •Where to Start
- •Transabdominal Approach
- •Transanal Approach
- •When to Transition to the Bottom
- •Roles and Assignments of the Dedicated Nurse and Surgical Assistant
- •Rendezvous: Meeting of the Planes
- •Top-to-Bottom Transfers
- •Extracting the Specimen and Creating the Anastomosis
- •Auditing Your Results
- •Conclusion
- •References
- •Introduction
- •Platform Options
- •Transanal Flexible Platforms (TAMIS Based)
- •Rigid Platforms
- •Semirigid Platforms (TEM/TAMIS Hybrid)
- •Conclusion
- •References
- •Introduction
- •Conclusion
- •References
- •25: Key Aspects of the Abdominal Dissection
- •Introduction
- •Positioning of taTME in Abdominal Maneuvers
- •Key Aspects for Performing TME from the Abdominal Side
- •Understanding the Perirectal Fascia Structure
- •Caution During the Dissection in the Neurovascular Bundle (NVB)
- •Key Aspects for Adequate Blood Flow Preservation in the Colon
- •Caution for the Abdominal Dissection Team in the Dual-Team taTME
- •Summary
- •References
- •Introduction
- •The Setup
- •Purse-String Principles
- •Common Pitfalls
- •Special Considerations
- •The Distal Purse-String
- •Preoperative Preparation
- •One Versus Two Teams
- •Abdominal Approach
- •Transanal Approach
- •Restorative Total Mesorectal Excision
- •Abdominoperineal Excision
- •Partial Mesorectal Excision
- •Critical Anatomic Landmarks
- •Specimen Extraction
- •Anastomosis
- •References
- •28: Strategies for Ultralow-Lying Rectal Cancer
- •Introduction
- •The Development of ISR for Rectal Cancer and a Farewell to the 2 cm Rule
- •Standard Educational Programs for taTME
- •General Technical Principles
- •taTME for Rullier Type I Tumors
- •taTME for Rullier Type II and III Tumors
- •Functional Outcomes
- •Oncologic Outcomes
- •Future Directions
- •References
- •Introduction
- •Conclusion
- •Suggested Reading
- •30: Urethral Injury: The New Challenge for taTME
- •Introduction
- •Incidence of Urethral Injury
- •Understanding the Anatomic Landmarks
- •Recognizing Patients at Risk
- •Intraoperative Prevention Strategies
- •Emerging Technologies
- •Conclusions
- •References
- •31: How to Avoid Urethral Injury in Males
- •Introduction
- •Assessment of Patient Risk for Injury
- •The Rectourethralis Muscle and the Pre-rectal Muscle Fibers of Luschka
- •Morphology of the Prostate Gland and Urethra
- •Anterior Exposure of the Puborectalis Muscle
- •Denonvilliers’ Fascia
- •The Neurovascular Bundle of Walsh
- •Surgeon Misperception and Visual Completion
- •Other Human Factors
- •Methods to Localize the Urethra
- •Urethral Injury Management
- •Related Injuries to the Urinary System
- •References
- •Introduction
- •Transanal Nerve-Sparing Mesorectal Dissection
- •Internal Anal Sphincter Nerves
- •Inferior Rectal Plexus
- •Neurovascular Bundles
- •Pelvic Splanchnic Nerves
- •Inferior Hypogastric Plexus
- •Hypogastric Nerve
- •References
- •Introduction
- •Operative Vectors
- •Gas Flow Mechanics
- •Cyclic Billowing
- •Anatomic Distortion
- •False Planes
- •References
- •Introduction
- •History
- •Nomenclature
- •Anatomy
- •Obtain Unimpeded Mesenteric Access
- •The Splenic Flexure
- •Future Directions
- •References
- •35: The Role for Perfusion Angiography
- •Fluorescence-Guided Surgery
- •Fluorophore Characteristics
- •Indocyanine Green (ICG)
- •Current Status of Perfusion Angiography in Colorectal Surgery
- •Clinical Outcomes in Colorectal Surgery
- •Changes in Management Decisions
- •Decision on the Use of Diverting Ileostomy
- •Ileo-Anal Pouch Assessment
- •Limitations
- •Current State of Data on PA to Reduce Anastomotic Leaks
- •Multifactorial Aetiology of AL
- •Targeted Fluorophores
- •Conclusions and Future Directions
- •References
- •36: Perioperative Preparation and Postoperative Care Considerations
- •Preoperative Assessment
- •History and Physical Examination
- •Preoperative Testing
- •Preoperative Stoma Marking
- •Sphincter Evaluation
- •Enhanced Recovery After Surgery (ERAS)
- •Preoperative
- •Intraoperative
- •Postoperative
- •Conclusion
- •References
- •Introduction
- •Full-Thickness Rectotomy
- •The Anastomosis
- •Other Complications
- •References
- •38: Functional Outcomes to Transanal Minimally Invasive Surgery (TAMIS) and Transanal Total Mesorectal Excision (taTME)
- •Anorectal Function and Assessment
- •Functional Outcomes: TAMIS
- •Functional Outcomes: taTME
- •References
- •39: Oncologic Outcomes
- •Grading of TME Specimen
- •Circumferential Resection Margin
- •Distal Resection Margin
- •Local Recurrence
- •Distant Metastasis
- •References
- •40: TaTME for Radical Exenteration
- •Introduction
- •Patient Indications
- •Anatomical Planning
- •Operative Approach
- •Platforms
- •Sphincter Preservation or En Bloc Perineal Resection
- •The Prostate, Seminal Vesicles, and Bladder
- •Female Patients and taTPE
- •Postoperative Considerations
- •References
- •Introduction
- •Anatomical Considerations
- •Operative Procedure
- •References
- •Introduction
- •Preoperative Planning
- •Operative Setup
- •Technique Description (Table 42.1)
- •taHR: Abdominal Aspects
- •taHR: Transanal Aspects
- •Results
- •Conclusion
- •References
- •43: Pure NOTES Transanal TME
- •Introduction
- •Rationale
- •Patient Selection
- •Surgical Technique
- •Armamentarium
- •Setup
- •Dissection
- •Step 1: Closing the Distal Stump of the Rectum Placing a Purse-String Suture
- •Step 2: Posterior Rectal Space Opening
- •Step 3: Cranial and Lateral Progression of the Dissection
- •Step 4: Extending the Perirectal Dissection Anteriorly
- •Step 6: Proceeding with the Dissection Toward the Root of the Mesorectum and the Retroperitoneal Abdominal Space
- •Step 7: Reaching the Root of the Inferior Mesenteric Vessels
- •Step 8: Dividing the Inferior Mesenteric Vessels and the Sigmoid Mesentery
- •Step 9: Construction of Low Colorectal or Coloanal Anastomosis
- •Postoperative Care
- •Discussion
- •Why Pure taTME?
- •Why TEO® Platform?
- •Why a Retroperitoneal Approach?
- •Is Mobilization of Splenic Flexure Necessary?
- •Teaching and Training
- •Conclusion
- •References
- •Introduction
- •Transanal Total Mesorectal Excision
- •Robotic Transanal Total Mesorectal Excision (Robotic taTME)
- •Surgical Technique
- •Clinical Outcomes
- •Future: New Robotics Platforms
- •References
- •Introduction
- •Flex® Robotic System
- •SPORT™ Surgical System
- •Da Vinci SP® Surgical System
- •References
- •Introduction
- •Mobile Apps
- •Video-in-Picture
- •Deferred Live Surgery
- •Conclusion
- •References
- •Introduction
- •Clinical Application
- •Conclusions
- •References
- •48: Current Controversies and Challenges in Transanal Total Mesorectal Excision (taTME)
- •Introduction
- •Comparison Between Open and Laparoscopic Approach
- •Comparison Between Laparoscopic and Robotic Approach
- •Comparison Between Laparoscopic and taTME Approach
- •Challenges
- •References
- •49: Transanal Total Mesorectal Excision: The Next 10 Years
- •What’s Best When and by Whom?
- •Educational Advances
- •Platform Advances
- •Instrumentation Advances
- •Visualization Advances
- •TaTME: A Killer Robot Application or Robot Killer?
- •Image-Guided Surgery

16 The Evolution ofRobotic TAMIS
Fig. 16.4 2012: The rst
robotic transanal excision
of a neoplasm in a human.
The da Vinci Si platform
was used in conjunction
with the GelPOINT Path
Transanal Access
Platform, the lesions were
completely excised, and
the defect reapproximated
robotically using barbed
absorbable suture. Note
the patient’s modied
Lloyd-Davies position and
the docking of the cart
over the right shoulder
Table 16.1 Chronological publications on robotic TAMIS
Author Date Country Interface Model n Remarks
Atallah [27] September
Atallah [36] May 2012 USA GelPOINT Human 1 1st robotic TAMIS in a human
Hompes [33] May 2012 UK Glove Cadaver 2 1st report of glove as interface for
Bardakcioglu
[37]
Atallah [47] June 2013 USA GelPOINT Human 1 1st robotic taTME in a human
Valls [42] August
Buchs [38] August
Hompes [40] April 2014 UK Glove Human 16
Atallah [48] June 2014 USA GelPOINT Human 3 1st pilot series on robotic taTME
Gómez-Ruiz
[49]
Atallah [41] February
Atallah [50] May 2015 USA GelPOINT
Kuo [51] October
Gómez-Ruiz
[46]
Erenler [45] April 2017 Turkey GelPOINT Human 1 1st published case using Xi
Marks [35] July 2017 USA GelPOINT Cadaver 12 1st preclinical series with da Vinci
Atallah [50] October
2011
December
2012
2013
2013
January
2015
2015
2016
December
2017
2017
USA GelPOINT Cadaver 2 1st experiment with robotic
USA GelPOINT Human 1 2nd robotic TAMIS in a human to
Spain Glove Human 1
Switzerland Glove Human 3 1st description of the lateral
Spain Custom Human 5 Totally robotic (above and below)
USA GelPOINT Human 18 Includes local excision, stula
LoneStar
Taiwan GelPOINT Human 15 Single port+1 combined with
Spain Custom Human 9 da Vinci Si utilizing specialized
USA Flex robot
port
Human 1 1st report of robotic taTME with
Cadaver 2 1st preclinical report utilizing
TAMIS
transanal robotic access
be reported
approach
taTME
repair, taTME
robotic ISR
robotic taTME
hybrid port
platform
SP
exible robotic system for TAMIS
and taTME
157

158
Fig. 16.5 Local excision via robotic TAMIS. 8 mm
wristed, instrumented, and stereoscopic magnied optics
are among the perceived advantages of the robotic platform. Here, rectal neoplasm boarders have been delineated with cautery marks, and a full-thickness excision is
in progress. A Maryland grasper and hook cautery are the
only instruments required to complete the excision
S. Atallah et al.
TAMIS remains limited, with mostly singlesurgeon retrospective series reported in the literature [39].
Docking andConguration
Today, docking of the multi-arm da Vinci robotic
cart can be performed in various methods and is
often predicated by surgeon preference, as well
as the specic platform’s design and interface.
For S and Si platforms, with the patient in dorsal
lithotomy, cart docking can be parallel and ush
against the operating table (Fig.16.6) or tangentially with the robotic arms delivered over the
shoulder. In general, the Xi® system with its long
Fig. 16.6 Docking and patient conguration is often
dependent on the specic robotic platform, the type of
TAMIS port or glove port, and sometimes the position of
the lesion. Surgeons who perform robotic TAMIS may
also have a specic preference; although for robotic
TAMIS (as compared to conventional TAMIS), there is
more likely to be position and docking variability.
Notwithstanding, one of the most common congurations
of the da Vinci Si systems with GelPOINT Path Transanal
Access Platform is shown. Note that the robotic cart is
docked ush with the operating table and working arms
one and two are delivered over the thigh to prevent
encroachment and collision during robotic TAMIS. The
patient is typically positioned in steep Trendelenburg

16 The Evolution ofRobotic TAMIS
Fig. 16.7 The Xi® system
has been docked
orthogonally to the
operating table, and the
patient’s steep
Trendelenburg, LloydDavies position is evident.
The low-prole arms and
large wingspan of the Xi
system allow for improved
transanal access with less
collision. Compared to the
Si, however, 5mm
effector arm instrumentation is not (currently)
available representing a
potential limitation since,
in general, it is advantageous to have small
diameter instruments so as
not to restrict workspace
®
arm span and low-prole conguration, provides
more leeway in cart-to-patient arrangement.
Common approaches using the Xi® system
include perpendicular docking relative to the
side of the operating table (Fig.16.7), but other
options are valid.
While TAMIS is almost always performed
with the patient in dorsal lithotomy, robotic
TAMIS may or may not require the patient to
be positioned in this fashion. Indeed, other
patient positioning may be desirable. For
example, anterior lesions are best approached
with the patient positioned prone jack-knife.
The advantage here is that the lower extremities do not collide with the working arms during the process of dissection, leaving the
effector arms with less likelihood for collision
(Fig.16.8).
In the spring of 2014, the da Vinci Xi
®
was
introduced, providing signicant advantages for
the operator, especially regarding versatility
with docking. The rst robotic TAMIS utilizing
the Xi® platform was believed to have been performed on July 28, 2015 by S.Atallah (Fig.16.9).
The rst published report using the Xi® was
reported in a video vignette by Erenler etal. in
2017 [45]. The Xi® platform allows for various
options in docking, and some experts prefer the
prone jack-knife position with orthogonal cart
159
Fig. 16.8 Common conguration for robotic TAMIS
using the Xi
pneumatics. Here, an anterior distal rectal lesion is targeted for local excision. Two working arms and a 30°
8 mm lens are mated to the TAMIS port. Note that the
GelPOINT Path Transanal Access Platform (TAMIS port)
is suspended by the hooks of the Lone Star Retractor,
which allows the access channel sleeve to be only partly
admitted into the anal canal. This allows for improved distal access for low-lying lesions
®
system is adapted with 5mm AirSeal for

160
S. Atallah et al.
Fig. 16.9 July 28, 2015: The rst robotic TAMIS using
®
the Xi
system was performed by S.Atallah in Orlando,
FL, USA. The lesion was a 2.8 cm adenoma and was
excised with negative margins. Note the conguration of
the working arms with a 30° downward lens placed superiorly and equidistant to two 8mm working arms. An additional 5mm AirSeal port (ConMed, Inc., Utica, NY, USA)
was used to provide stable pneumorectum. This fourth port
allows for access of 5mm instruments (such as a suction
irrigator) which can be operated by a bedside assistant
positioning for anterior rectal wall pathology.
Another option is the lateral approach, which
when combined with a glove port results in
improved robotic arm excursion, as demonstrated by N.Buchs in 2013 with the Si system
[38]. Furthermore, Gómez-Ruiz et al. have
described the use of a specialized interface in
which the platform is part rigid and bedrail
mounted and part reusable. The rigid portion is
similar to a 40mm dia. TEM scope, but the faceplate utilizes an 80 mm GelPOINT membrane
that is twice the diameter of the standard TAMIS
port (Fig.16.10). This likely allows for improved
instrument maneuverability, decreased arm collisions, and a simplication of the port-to-robot
rendezvous.
Fig. 16.10 A custom- made port, developed by Marcos
Gómez-Ruiz, MD, is a hybrid cross between a TEM scope
and a TAMIS port. The rigid reusable portion of the device
is secured to the bedrail with a mount to hold it in position. The faceplate (disposable) is an 80mm GelPOINT
(Applied Medical, Inc.). The conguration improves
ergonomics and decreases collisions between working
arms
Applications ofRobotics Beyond
Local Excision
In 2013, just 3years after the rst reported human
case of taTME by P.Sylla and A.Lacy, robotic
taTME was successfully performed on a human
for the rst time [54]. The patient was an obese
female with familial adenomatous polyposis
(FAP) syndrome and synchronous hepatic exure
and rectal cancers. The abdominal resection was
performed laparoscopically, and the taTME was
performed by docking the da Vinci Si transanally
with GelPOINT Path Access Platform as an interface. While there were limitations of reach, the
robotic taTME was successfully completed in
87 min; the mesorectal envelop contained one

16 The Evolution ofRobotic TAMIS
161
defect measuring 1.5 cm and therefore was
graded as a Quirke II (near complete); all margins were negative [54].
While limited to expert centers, small series
and pilot studies on robotic taTME have been published in both the preclinical and clinical settings
[47–49, 51, 55, 56], each series concluding that
high-quality excision is feasible with the robotic
platform (Fig. 16.11). Although most robotic
approaches to taTME have applied the platform
transanally in conjunction with laparoscopy for
the abdominal portion of the operation, Marcos
Gómez-Ruiz has used a totally robotic approach
by double docking abdominally and then subsequently transanally [49]. This technique utilizes a
specialized platform that is a hybrid between TEM
and TAMIS with some components reusable and
others disposable, as described previously.
There has been an accelerated advancement in
minimally invasive approaches to transanal surgery over recent years (Fig. 16.12). Robotic
approaches are continuing to evolve with several
new venders rapidly lling the space with creative systems that, instead of mimicking laparoscopy, are being designed with computerized,
remodeled mechanics that provide improved
exibility and thus an ability to access anatomic
targets not previously believed possible [50, 57].
Today, much of the focus on robotic transanal
surgery is toward the development of taTME,
with the objective of improving the operative
approach and reducing the challenges of conventional instrumentation [58–60]. Image-guided
surgery in conjunction with robotics for complex
surgical procedures, such as taTME, is also an
area actively being investigated. Robotic taTME
is discussed further in Chap. 44.
Fig. 16.11 Robotic taTME represents the next step in the
evolution of advanced, robotic transanal access. Here the
da Vinci Si platform with a 5mm hook monopolar cautery
and 5mm grasper is used to initiate the posterior TME
dissection. The theoretical advantage of the robotics in a
conned space is the potential to improve resection quality by providing a platform with superior optics, magnication, and surgeon control
2012 : First Glove Port
for Robotics TAMIS
2011 : First Robotic
TAMIS Cadaveric
Experimentation
2013: First
Robotic taTME
2012: First
Robotic TAMIS
in a human
2017 : First
Cadaveric Report
using SP System
2015: First Xi
System for
robotic TAMIS
2017: First
Robotic TAMIS
and taTME
(Cadaveric)
With Flexible
Roboitc System
®
1984: TEM
Developed
2001: First Robotic
Prostatectomy
2001: Transcontinental
Robotic Surgery
~1999: Sugical
Robotics Introduced
2002: First
Robotic
Colectomy
2009 : First
TAMIS
2009 : First
Abdominal Robotic
Single Port Surgery
2010: First
Robotic Transanal
Surgery Dry Lab
Experiments
Fig. 16.12 Timeline delineating the milestones in robotics in colorectal surgery including transanal approaches

162
S. Atallah et al.
References
1. Marescaux J, Leroy J, Rubino F, Smith M, Vix M,
Simone M, Mutter D.Transcontinental robot-assisted
remote telesurgery: feasibility and potential applications. Ann Surg. 2002;235(4):487.
2. Marescaux J, Leroy J, Gagner M, Rubino F, Mutter
D, Vix M, Butner SE, Smith MK.Transatlantic robotassisted telesurgery. Nature. 2001;413(6854):379.
3. Kappert U, Cichon R, Schneider J, Gulielmos V,
Tugtekin SM, Matschke K, Schramm I, Schueler
S.Closed-chest coronary artery surgery on the beating heart with the use of a robotic system. J Thorac
Cardiovasc Surg. 2000;120(4):809–11.
4. Falk V, Diegler A, Walther T, Autschbach R, Mohr
FW. Developments in robotic cardiac surgery. Curr
Opin Cardiol. 2000;15(6):378–87.
5. Chitwood WR, Nifong LW, Elbeery JE, Chapman
WH, Albrecht R, Kim V, Young JA. Robotic
mitral valve repair: trapezoidal resection and prosthetic annuloplasty with the da Vinci surgical
system. J Thorac Cardiovasc Surg. 2000;120(6):
1171–2.
6. Mohr FW, Falk V, Diegeler A, Walther T, Gummert
JF, Bucerius J, Jacobs S, Autschbach R.Computerenhanced “robotic” cardiac surgery: experience in
148 patients. J Thorac Cardiovasc Surg. 2001;121(5):
842–53.
7. Zenati MA. Robotic heart surgery. Cardiol Rev.
2001;9(5):287–94.
8. Binder J, Kramer W.Robotically-assisted laparoscopic
radical prostatectomy. BJU Int. 2001;87(4):408–10.
9. Pasticier G, Rietbergen JB, Guillonneau B, Fromont
G, Menon M, Vallancien G.Robotically assisted laparoscopic radical prostatectomy: feasibility study in
men. Eur Urol. 2001;40(1):70–4.
10. Abbou CC, Hoznek A, Salomon L, Olsson LE,
Lobontiu A, Saint F, Cicco A, Antiphon P, Chopin
D.Laparoscopic radical prostatectomy with a remote
controlled robot. J Urol. 2001;165(6):1964–6.
11. Weber PA, Merola S, Wasielewski A, Ballantyne
GH. Telerobotic-assisted laparoscopic right and
sigmoid colectomies for benign disease. Dis Colon
Rectum. 2002;45(12):1689–96.
12. Talamini M, Campbell K, Staneld C. Robotic
gastrointestinal surgery: early experience and system description. J Laparoendosc Adv Surg Tech.
2002;12(4):225–32.
13. Baek SJ, Kwak JM, Kim J, Kim SH, Park S, Korean
Association of Robotic Surgeons (KAROS) Study
Group. Robotic rectal surgery in Korea: analysis of
a nationwide registry. Int J Med Robot. 2018; https://
doi.org/10.1002/rcs.1896. [Epub ahead of print].
14. Kwak JM, Kim SH.Robotic surgery for rectal cancer:
an update in 2015. Cancer Res Treat. 2016;48(2):427–
35. https://doi.org/10.4143/crt.2015.478. Epub 2016
Feb 3.
15. Ngu JC, Tsang CB, Koh DC. The da Vinci Xi: a
review of its capabilities, versatility, and potential
role in robotic colorectal surgery. Robot Surg Res
Rev. 2017;4:77–85. https://doi.org/10.2147/RSRR.
S119317.
16. Kim J, Baek SJ, Kang DW, Roh YE, Lee JW, Kwak
HD, Kwak JM, Kim SH.Robotic resection is a good
prognostic factor in rectal cancer compared with
laparoscopic resection: long-term survival analysis using propensity score matching. Dis Colon
Rectum. 2017;60(3):266–73. https://doi.org/10.1097/
DCR.0000000000000770.
17. Yoo BE, Cho JS, Shin JW, Lee DW, Kwak JM,
Kim J, Kim SH.Robotic versus laparoscopic intersphincteric resection for low rectal cancer: comparison of the operative, oncological, and functional
outcomes. Ann Surg Oncol. 2015;22(4):1219–25.
https://doi.org/10.1245/s10434-014-4177-5. Epub
2014 Oct 18.
18. Baek SJ, Kim CH, Cho MS, Bae SU, Hur H, Min BS,
Baik SH, Lee KY, Kim NK.Robotic surgery for rectal cancer can over- come difculties associated with
pelvic anatomy. Surg Endosc. 2015;29(6):1419–24.
https://doi.org/10.1007/s00464-014-3818-x.
19. Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N,
Copeland J, Quirke P, West N, Rautio T, Thomassen
N, Tilney H, Gudgeon M, Bianchi PP, Edlin R, Hulme
C, Brown J.Effect of robotic- assisted vs conventional
laparoscopic surgery on risk of conversion to open
laparotomy among patients undergoing resection for
rectal cancer. JAMA. 2017;318(16):1569–80. https://
doi.org/10.1001/jama.2017.7219.
20. Pai A, Melich G, Marecik SJ, Park JJ, Prasad
LM. Current status of robotic surgery for rectal
cancer: a bird’s eye view. J Minim Access Surg.
2015;11(1):29.
21. Pai A, Marecik SJ, Park JJ, Melich G, Sulo S, Prasad
LM. Oncologic and clinicopathologic outcomes of
robot-assisted total mesorectal excision for rectal cancer. Dis Colon Rectum. 2015;58(7):659–67.
22. Pigazzi A, Luca F, Patriti A, et al. Multicentric
study on robotic tumor-specic mesorectal excision
for the treatment of rectal cancer. Ann Surg Oncol.
2010;17:1614–20.
23. Atallah S, Albert M, Larach S.Transanal minimally
invasive surgery: a giant leap forward. Surg Endosc.
2010;24(9):2200–5.
24. Kaouk JH, Goel RK, Haber GP, Crouzet S, Stein
RJ. Robotic single-port transumbilical surgery in
humans: initial report. BJU Int. 2009;103(3):366–9.
25. Wren SM, Curet MJ.Single-port robotic cholecystectomy: results from a rst human use clinical study of
the new da Vinci single-site surgical platform. Arch
Surg. 2011;146(10):1122–7.
26. Kroh M, El-Hayek K, Rosenblatt S, Chand B, Escobar
P, Kaouk J, Chalikonda S. First human surgery with
a novel single-port robotic system: cholecystectomy
using the da Vinci single-site platform. Surg Endosc.
2011;25(11):3566.
27. Atallah SB, Albert MR, deBeche-Adams TH, Larach
SW. Robotic transanal minimally invasive surgery in
a cadaveric model. Tech Coloproctol. 2011;15(4):

16 The Evolution ofRobotic TAMIS
163
461–4. https://doi.org/10.1007/s10151-011-0762-9.
Epub 2011 Sep 28.
28. Atallah S, Keller D.Why the conventional parks transanal excision for early stage rectal cancer should be
abandoned. Dis Colon Rectum. 2015;58(12):1211–4.
https://doi.org/10.1097/DCR.0000000000000470.
29. Moore JS, Cataldo PA, Osler T, Hyman NH.Transanal
endoscopic microsurgery is more effective than traditional transanal excision for resection of rectal
masses. Dis Colon Rectum. 2008;51:1026–30.
30. de Graaf EJ, Burger JW, van Ijsseldijk AL, Tetteroo
GW, Dawson I, Hop WC. Transanal endoscopic
microsurgery is superior to transanal excision of rectal adenomas. Color Dis. 2011;13:762–7.
31. Christoforidis D, Cho HM, Dixon MR, Mellgren
AF, Madoff RD, Finne CO. Transanal endoscopic
microsurgery versus conventional transanal excision for patients with early rectal cancer. Ann Surg.
2009;249:776–82.
32. Carrara A, Mangiola D, Motter M, etal. Glove port
technique for transanal endoscopic microsurgery. Int
J Surg Oncol. 2012;2012:383025.
33. Hompes R, Rauh SM, Hagen ME, Mortensen
NJ. Preclinical cadaveric study of transanal endoscopic da Vinci
®
surgery. Br J Surg.
2012;99(8):1144–8. https://doi.org/10.1002/
bjs.8794. Epub 2012 May 22.
34. Atallah S. Robotic transanal minimally invasive surgery for local excision of rectal neoplasms (Br J Surg
2014; 101: 578–581). Br J Surg. 2014;101(5):581.
https://doi.org/10.1002/bjs.9467.
35. Marks J, Ng S, Mak T. Robotic transanal surgery (RTAS) with utilization of a next-generation
single-port system: a cadaveric feasibility study.
Tech Coloproctol. 2017;21(7):541–5. https://doi.
org/10.1007/s10151-017-1655-3. Epub 2017 Jul 14.
36. Atallah S, Parra-Davila E, DeBeche-Adams T, Albert
M, Larach S. Excision of a rectal neoplasm using
robotic transanal surgery (RTS): a description of the
technique. Tech Coloproctol. 2012;16(5):389–92.
https://doi.org/10.1007/s10151-012-0833-6. Epub
2012 May 15.
37. Bardakcioglu O. Robotic transanal access surgery. Surg Endosc. 2013;27(4):1407–9. https://doi.
org/10.1007/s00464-012-2581-0. Epub 2012 Dec 13.
38. Buchs NC, Pugin F, Volonte F, Hagen ME, Morel
P, Ris F. Robotic transanal endoscopic microsurgery: technical details for the lateral approach. Dis
Colon Rectum. 2013;56(10):1194–8. https://doi.
org/10.1097/DCR.0b013e3182a2ac84.
39. Martin-Perez B, Andrade-Ribeiro GD, Hunter
L, Atallah S. A systematic review of transanal
minimally invasive surgery (TAMIS) from 2010
to 2013. Tech Coloproctol. 2014;18(9):775–88.
https://doi.org/10.1007/s10151-014-1148-6. Epub
2014 May 7.
40. Hompes R, Rauh SM, Ris F, Tuynman JB, Mortensen
NJ. Robotic transanal minimally invasive surgery
for local excision of rectal neoplasms. Br J Surg.
2014;101(5):578–81. https://doi.org/10.1002/bjs.9454.
41. Atallah S, Martin-Perez B, Parra-Davila E, deBecheAdams T, Nassif G, Albert M, Larach S. Robotic
transanal surgery for local excision of rectal neoplasia, transanal total mesorectal excision, and repair
of complex stulae: clinical experience with the rst
18 cases at a single institution. Tech Coloproctol.
2015;19(7):401–10. https://doi.org/10.1007/s10151-
015-1283-8. Epub 2015 Feb 24.
42. Vallribera Valls F, Espín Bassany E, JiménezGómez LM, Ribera Chavarría J, Armengol Carrasco
M. Robotic transanal endoscopic microsurgery in
benign rectal tumour. J Robot Surg. 2014;8(3):277–
80. https://doi.org/10.1007/s11701-013-0429-9. Epub
2013 Aug 10.
43. Atallah S, Quinteros F, Martin-Perez B, Larach
S.Robotic transanal surgery for local excision of rectal neoplasms. J Robot Surg. 2014;8(2):193–4. https://
doi.org/10.1007/s11701-014-0463-2. Epub 2014 Apr
22.
44. Harr JN, Obias V. Robotic-assisted transanal excision of a large rectal mass–a video vignette. Color
Dis. 2016;18(1):107–8. https://doi.org/10.1111/
codi.13146.
45. Erenler I, Aytac E, Bilgin IA, Baca B, Hamzaoglu
I, Karahasanoglu T. Robotic transanal minimally
invasive surgery (R-TAMIS) with the da Vinci Xi
System– a video vignette. Color Dis. 2017;19(4):401.
https://doi.org/10.1111/codi.13638.
46. Gómez Ruiz M, Cagigas Fernández C, Alonso Martín
J, Cristobal Poch L, Manuel Palazuelos C, Barredo
Cañibano FJ, Gómez Fleitas M, Castillo Diego
J.Robotic assisted transanal polypectomies: is there
any indication? Cir Esp. 2017;95(10):601–9. https://
doi.org/10.1016/j.ciresp.2017.09.006. Epub 2017
Nov 14.
47. Atallah S, Martin-Perez B, Pinan J, Quinteros F,
Schoonyoung H, Albert M, Larach S.Robotic transanal total mesorectal excision: a pilot study. Tech
Coloproctol. 2014;18(11):1047–53. https://doi.
org/10.1007/s10151-014-1181-5. Epub 2014 Jun 24.
48. Kuo L, Ngu JC, Tong Y, etal. Combined robotic transanal total mesorectal excision (R-taTME) and singlesite plus one-port (R-SSPO) technique for ultra-low
rectal surgery—initial experience with a new operation approach. Int J Color Dis. 2017;32(2):249–54.
https://doi.org/10.1007/s00384-016-2686-3.
49. Gómez Ruiz M, Parra IM, Palazuelos CM, Martín
JA, Fernández CC, Diego JC, Fleitas MG.Roboticassisted laparoscopic transanal total mesorectal
excision for rectal cancer: a prospective pilot study.
Dis Colon Rectum. 2015;58(1):145–53. https://doi.
org/10.1097/DCR.0000000000000265.
50. Atallah S. Assessment of a exible robotic system
for endoluminal applications and transanal total
mesorectal excision (taTME): could this be the solution we have been searching for? Tech Coloproctol.
2017;21(10):809–14. https://doi.org/10.1007/s10151-
017-1697-6. Epub 2017 Oct 24.
51. Kuo LJ, Ngu JC, Tong YS, Chen CC. Combined
robotic transanal total mesorectal excision (R-taTME)

164
S. Atallah et al.
and single-site plus one-port (R-SSPO) technique for
ultra-low rectal surgery-initial experience with a new
operation approach. Int J Color Dis. 2017;32(2):249–
54. https://doi.org/10.1007/s00384-016-2686-3. Epub
2016 Oct 15.
52. Laird R, Obias VJ.Robotic transanal stula repair– a
video vignette. Color Dis. 2015;17(1):90. https://doi.
org/10.1111/codi.12799.
53. Stack ME, Umanskiy K. Robotic-assisted transanal
repair of a rectovaginal stula. J Gastrointest Surg.
2016;20(12):2106. Epub 2016 May 24.
54. Atallah S, Nassif G, Polavarapu H, deBeche-Adams
T, Ouyang J, Albert M, Larach S. Robotic-assisted
transanal surgery for total mesorectal excision (RATSTME): a description of a novel surgical approach
with video demonstration. Tech Coloproctol.
2013;17(4):441–7. https://doi.org/10.1007/s10151-
013-1039-2. Epub 2013 Jun 26.
55. Gomez Ruiz M, Martin Parra I, Calleja Iglesias A,
Stein H, Sprinkle S, Manuel Palazuelos C, Alonso
Martin J, Cagigas Fernandez C, Castillo Diego J,
Gomez Fleitas M. Preclinical cadaveric study of
transanal robotic proctectomy with total mesorectal excision combined with laparoscopic assistance.
Int J Med Robot. 2015;11(2):188–93. https://doi.
org/10.1002/rcs.1581. Epub 2014 Feb 27.
56. Atallah S, Drake J, Martin-Perez B, Kang C, Larach
S. Robotic transanal total mesorectal excision with
intersphincteric dissection for extreme distal rectal
cancer: a video demonstration. Tech Coloproctol.
2015;19(7):435. https://doi.org/10.1007/s10151-015-
1304-7. Epub 2015 May 12.
57. Son J, Cho CN, Kim KG, Chang TY, Jung H, Kim SC,
Kim MT, Yang N, Kim TY, Sohn DK.A novel semiautomatic snake robot for natural orice transluminal
endoscopic surgery: preclinical tests in animal and
human cadaver models (with video). Surg Endosc.
2015;29(6):1643–7. https://doi.org/10.1007/s00464-
014-3854-6. Epub 2014 Oct 8.
58. Melani AF, Diana M, Marescaux J. The quest for
precision in transanal total mesorectal excision. Tech
Coloproctol. 2016;20(1):11–8.
59. Hompes R. Robotics and transanal minimal invasive surgery (TAMIS): the “sweet spot” for robotics in colorectal surgery? Tech Coloproctol.
2015;19(7):377–8. https://doi.org/10.1007/s10151-
015-1326-1. Epub 2015 Jun 25.
60. Mohd Azman ZA, Kim SH.A review on robotic surgery in rectal cancer. Transl Gastroenterol Hepatol.
2016;1:5. https://doi.org/10.21037/tgh.2016.03.16.
eCollection 2016.

Transanal Robotic Surgery
andFuture Directions
KevinM.Izquierdo, ThushySiva, JeanSalem,
BrigitteAnderson, andJohnMarks
Abbreviations
MIS Minimally invasive surgery
NOTES Natural orice transluminal
endoscopic surgery
RATS-TME Robotic transanal total mesorec-
tal excision; robotic taTME
RTAS Robotic transanal surgery
SILS Single incision laparoscopic surgery
TAMIS Transanal minimally invasive
surgery
TATA Transanal transabdominal
proctosigmoidectomy
taTME Transanal total mesorectal excision
TEM Transanal endoscopic
microsurgery
K. M. Izquierdo (*) · J. Salem
Lankenau Medical Center, Division of Colorectal
Surgery, Wynnewood, PA, USA
e-mail: salemj@mlhs.org
T. Siva
Easton Hospital, Department of Surgery,
Easton, PA, USA
B. Anderson · J. Marks
Colon and Rectal Surgery, Lankenau Medical Center,
Marks Colorectal Surgical Associates, Wynnewood,
PA, USA
e-mail: crresearch@mlhs.org; marksj@mlhs.org
17
Introduction
The challenges inherent to rectal cancer surgery
have inspired ideological innovations in the eld.
Driven by high recurrence rates and high morbidity seen with the earliest rectal cancer operations,
and by the technical difculty of operating in the
deep and narrow connes of the pelvis, the surgical treatment of rectal cancer has continued to
evolve. The total mesorectal excision (TME) as
described by Dr. Bill Heald [1] and the transanal
transabdominal proctosigmoidectomy (TATA) as
described by Dr. Gerald Marks [2], which ensures
a clear distal margin in the rectum pre-treated
with radiation, have both become core oncologic
tenets of rectal cancer surgery. Furthermore, the
TATA allows sphincter preservation, even for
patients with low rectal cancers, without sacricing the quality of oncologic outcomes [3].
Combined with TEM, these concepts have given
rise to the transanal total mesorectal excision
(taTME).
Benets and advances in minimally invasive
surgery (MIS) have been applied successfully to
rectal cancer surgery. Prior to the 1980s, transanal excision of rectal neoplasms was restricted
by limited reach and exposure. In 1983, Dr.
Gerhard Buess invented transanal endoscopic
microsurgery (TEM) [4], setting the stage for a
long technological evolution in rectal surgery.
Building off of Dr. Buess’ TEM technique, the
© Springer Nature Switzerland AG 2019
S. Atallah (ed.), Transanal Minimally Invasive Surgery (TAMIS) and Transanal Total Mesorectal
Excision (taTME), https://doi.org/10.1007/978-3-030-11572-2_17
165

166
K. M. Izquierdo et al.
applications of transanal surgery have been
extended by Atallah, Albert, and Larach using
single-port transanal laparoscopy, today known
as transanal minimally invasive surgery (TAMIS);
and most recently, robotic surgical technology is
applied transanally (Robotic TAMIS). By
addressing many of the technical challenges that
have hindered wider adoption of TEM, TAMIS,
and taTME, robotic transanal surgery promises to
increase surgeon access to these techniques so
that more patients can benet. Future directions
of transanal robotic surgery will undoubtedly
lead to a new era of pure natural orice transluminal endoscopic surgery (NOTES), the ultimate
in minimally invasive surgery.
Evolution ofTransanal Surgery
Dr. Gerhard Buess’ transanal endoscopic microsurgery (TEM) platform in 1983 represented a
disruptive change in surgical approach and technology. TEM predates laparoscopy – the rst
demonstration of the laparoscopic cholecystectomy was presented in 1989 at the Surgical
Association of Gastrointestinal and Endoscopic
Surgeons (SAGES) conference by Drs. Perissat
and Mouiel [5, 6]. In 1983, open surgery was the
only approach in the surgical treatment of rectal
cancer. The original application of TEM was in
the removal of rectal polyps and was later
expanded to treating malignant lesions with local
excision. Although unpublished, it is believed
that in 2008 Dr. John Marks performed the rst
transanal total mesorectal excision (taTME)
using the TEM platform.
Key technological features of TEM are binocular stereotactic optics, improved access to
more proximal lesions, and incisionless natural
orice surgery via the anus. As applications of
TEM expanded to T1 cancers, the technical
advantages became evident with signicantly
lower recurrence rates as compared to open transanal approaches. Experiences at the University of
Minnesota and the Cleveland Clinic reported
local recurrence rates of 4.2–9% with TEM compared to 25–33% with conventional transanal
excision for T1 rectal cancers [7, 8]. This disruptive transanal minimally invasive approach set
the stage for the rapid evolution of technology in
colorectal surgery over the next three decades.
However, the steep learning curve and signicant
cost were major barriers to its universal
adoption.
Transanal minimally invasive surgery
(TAMIS), rst described in 2009 by Drs. Atallah,
Albert, and Larach, is a cost-effective alternative
to TEM [9]. Building upon TEM concepts,
TAMIS uses a exible single incision laparoscopic surgery (SILS) port transanally rather than
the rigid proctoscope used in TEM. Cost is
decreased by avoiding the large start-up cost of
TEM equipment and through the use of laparoscopic instrumentation readily available in
modern- day operating rooms. Atallah etal. published their experience with TAMIS in the excision of both malignant and benign lesions of the
rectum, and early data suggests that oncologic
outcomes are comparable to TEM [10].
From a technical standpoint, TAMIS, allows
access to the full 360 degrees of the lumen,
whereas with TEM, the workspace is limited to
the lower 180 degrees of the visualized operative
eld. Furthermore, the exible platform allows
better access to more proximal structures, allowing its application to expand to complete transanal total mesorectal excision. However, TAMIS
initially suffered from the lack of a stable pneumatic platform that TEM provides. Drs. Lacy,
Rattner, and Sylla published a systematic study
of the transanal total mesorectal excision using
the TAMIS platform [11]. In doing so, they successfully melded the core principles of TATA,
hybrid NOTES, and TAMIS.
Pushing the limits of transanal surgery using
the TAMIS technique, Dr. Leroy pioneered
“pure” NOTES proctosigmoidectomy with transanal completion of the TME dissection, release
of the splenic exure, transection of the inferior
mesenteric vessels, and coloanal anastomosis. He
coined the procedure perirectal oncologic gateway for retroperitoneal endoscopic single site
surgery (PROGRESSS) [12]. Select centers have
further pioneered pure NOTES taTME [13, 14].
As it was with TEM for local excision of rectal lesions, a steep learning curve is the primary
obstacle to wider adoption of pure NOTES for
rectal cancer as it requires the highest level of
Соседние файлы в папке Библиотека им академика М.И. Перельмана
